Utility of preoperative chemoradiotherapy for advanced esophageal carcinoma
Authors:
- 4 April 2012
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 27, 88-94
Abstract
The most effective treatment would be neoadjuvant chemoradiotherapy (NACRT) plus surgery with three-field lymphadenectomy, if tolerability and complications are acceptable. The aim of this prospective study was to evaluate the tolerability of NACRT+ systematic three-field lymphadenectomy. A total of 127 cases of advanced esophageal carcinoma were objected, among which 32 had NACRT, being the cases suspected to cT3-T4 or, < cT3 with multiple lymph node metastasis. ≥ T2 of 95 cases were treated by surgery alone (NACRT [-] case). The effect of NACRT was evaluated by histological examination and corrected with the clinicopathologic factors, including postoperative prognosis. After reports JCOG9907, we treated eight cases with neoadjuvant chemotherapy at stages II and III. We examined Musashi-1 staining for these eight cases. Histological good response to NACRT group showed good prognosis. Lymph node metastasis is a predictive factor for prognosis. In this additional study, Musashi-1 was positive after neoadjuvant chemotherapy in three cases. The histological response was grade 1 in all of them and recurrence was observed within a short period of time. Two cases of grade 3 were negative staining to Musashi-1 and showed no recurrence. This study shows that NACRT plus surgery with three-field lymphadenectomy is a feasible therapeutic approach for the cases with multiple lymph node metastases. Prognosis was significantly better in cases with marked histological improvement. It is important to find the predictive factors of histological improvement. Musashi-1 might be a candidate maker for histological response and prognosis, and further studies are needed to prove it.Keywords
This publication has 32 references indexed in Scilit:
- A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)Annals of Surgical Oncology, 2011
- INDICATION AND LIMITATION OF 3-FIELD LYMPH NODE DISSECTION SURGERY FOR ESOPHAGEAL CANCER FROM SURVIVAL ANALYSISNihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association), 2007
- A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancerThe American Journal of Surgery, 2003
- Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal CarcinomaJournal of Clinical Oncology, 2001
- Localization of initial lymph node metastasis from carcinoma of the thoracic esophagusCancer, 2000
- Indications and Limitations of 3-Field Lymph Node Dissection for Thoracic Esophageal Carcinoma.The Japanese Journal of Gastroenterological Surgery, 1999
- Significance of Lymph Node Dissection of Neck and Upper Mediastinum according to Metastatic Analysis of 3-Field Dissection for Cancer of the Thoracic Esophagus.The Japanese Journal of Gastroenterological Surgery, 1999
- Results of 3-field Lymph Node Dissection for Esophageal Cancer by Depth of Invasion and State of Lymphatic Metastasis.The Japanese Journal of Gastroenterological Surgery, 1999
- The number of lymph node metastases influences survival in esophageal cancerJournal of Surgical Oncology, 1998
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992